LIPG and breast cancer: To translate our findings into a therapeutic approach for breast cancer treatment, we identified a new LIPG inhibitor, cynaroside isolated from the herbal plant dandelion, and confirmed that the inhibition of LIPG is a promising strategy to combat TNBC tumor growth.